Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amal Mechaal"'
Autor:
Asma Ounalli, Imen Moumni, Amal Mechaal, Aya Chakroun, Mbarka Barmat, Rim El Elj Rhim, Samia Menif, Ines Safra
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundGenetic variations in TP53 gene are known to be important in chronic lymphocytic leukemia (CLL) and may cause its inactivation which is associated with an aggressive form of the disease. Single nucleotide polymorphism (rs1042522:G>C) in TP5
Externí odkaz:
https://doaj.org/article/861ae5c3c4f14461a3a0488c10b6ac63
Autor:
Amir Hossein Hasanpour, Mahdi Sepidarkish, Abolfazl Mollalo, Ali Ardekani, Mustafa Almukhtar, Amal Mechaal, Seyed Reza Hosseini, Masoumeh Bayani, Mostafa Javanian, Ali Rostami
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 12, Iss 1, Pp 1-11 (2023)
Abstract Background Methicillin-resistant Staphylococcus aureus (MRSA) is a difficult to treat infection, particularly in residents of elderly care centers (ECCs). Despite the substantial burden of MRSA, an inadequate number of studies have analyzed
Externí odkaz:
https://doaj.org/article/00a995df127448c88f28754a491914a7
Autor:
Reza Naeimi, Mahdi Sepidarkish, Abolfazl Mollalo, Hamid Parsa, Sanaz Mahjour, Fatemeh Safarpour, Mustafa Almukhtar, Amal Mechaal, Hiam Chemaitelly, Behnam Sartip, Elika Marhoommirzabak, Ali Ardekani, Peter J. Hotez, Robin B. Gasser, Ali Rostami
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101786- (2023)
Summary: Background: The higher hospitalisation rates of those aged 0–19 years (referred to herein as ‘children’) observed since the emergence of the immune-evasive SARS-CoV-2 Omicron variant and subvariants, along with the persisting vaccinati
Externí odkaz:
https://doaj.org/article/ecdec6379d024d60adcdf18e7746a9e0
Autor:
Reza Naeimi, Mahdi Sepidarkish, Abolfazl Mollalo, Hamid Parsa, Sanaz Mahjour, Fatemeh Safarpour, Mustafa Almukhtar, Amal Mechaal, Hiam Chemaitelly, Behnam Sartip, Elika Marhoommirzabak, Ali Ardekani, Peter J. Hotez, Robin B. Gasser, Ali Rostami
Publikováno v:
EClinicalMedicine. 56
The higher hospitalisation rates of those aged 0-19 years (referred to herein as 'children') observed since the emergence of the immune-evasive SARS-CoV-2 Omicron variant and subvariants, along with the persisting vaccination disparities highlighted
Publikováno v:
Advances in Medical Sciences. 64:395-401
Acute myeloid leukemia (AML) is a heterogeneous disease. The discovery of novel discriminative biomarkers remains of utmost value for improving outcome predictions. Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase of H3K27me3. It is
Autor:
Taha Y. Taha, Irum Khan, Dolores Mahmud, Rajeev Ranjan, Amal Mechaal, Amudha Ganapathy, Pavel A. Petukhov, Nadim Mahmud
Publikováno v:
Blood. 138:2944-2944
The treatment outcomes for patients diagnosed with acute myeloid leukemia (AML) are still dismal. Recent advances in understanding AML indicate that the lack of efficacy is primarily due to non-specificity of currently used chemotherapeutics targetin